The drug industry’s care gap; Novo aims to diversify; and more

Welcome back to Endpoints Weekly. We unveiled this year’s Endpoints 11 at a gala event in Boston on Thursday. You can meet the class of 2026 here ... Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act…

Source: Endpoints News